生命科学资讯

Lilly slightly lowers self-pay prices for single-dose vials of Zepbound

Biopharma Sentiment Index | Q4 2025

"Heavy AI" is taking over biopharma | Signal Pulse Report

Introducing Endpoints Signal — intelligence for fresh biopharma insights

Gene writing startup Tessera strikes $150M partnership with Regeneron

Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqel

Generate:Biomedicines to start Phase 3 studies for TSLP antibody

Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS says

Lundbeck backs out of bidding war for sleep disorder biotech Avadel

Novo submits high-dose Wegovy for FDA approval using voucher

Delayed panel on vaccine injury payments to meet next month

Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer

FDA pushes back Ascendis' dwarfism drug decision date by three months

China's Zhongmou seeks to create a ‘one-size-fits-all’ rival to Luxturna

Cormorant eyes another $400M healthcare fund

Sanofi headquarters raided in broader French tax fraud investigation

Kallyope scraps one of two mid-stage migraine drugs

Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgAN

CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second round

What a team of ex-Amazon employees are building next in healthcare